Dr Reddy's Laboratories on October 24 reported a 7 percent year-on-year rise in net profit to Rs 1,347.1 crore in Q2 FY26.

Generic drugmaker Dr Reddy's Labs reported 7% growth in its net profit at Rs 1,347 crore in the September quarter, compared with Rs 1,255 crore in the same quarter of last year. Revenue from ...

HYDERABAD, India (AP) — HYDERABAD, India (AP) — Dr. Reddy’s Laboratories Ltd. (RDY) on Friday reported earnings of $162 million in its fiscal second quarter. On a per-share basis, the Hyderabad, India ...

Dr. Reddy's Laboratories reported consolidated revenues of ₹8,805 crore in Q2FY26, up 9.8% year-on-year and 3% sequentially. Profit after tax rose 14% to ₹1,437 crore, while EBITDA stood at ₹2,351 ...

The brokerage has maintained a ‘Positive’ sector view, forecasting EBITDA margins to remain “broadly stable” as companies focus on improving their product mix.

(RTTNews) - Dr. Reddy's Laboratories Ltd. (ROY) reported, under IFRS standards, that its second quarter profit attributable to equity holders of the parent company increased to INR 14.37 billion or ...

Stay updated with the latest news on Dr Reddy's Laboratories. Explore breaking news headlines about Dr Reddy's Laboratories and more ...

Indian markets open positively with GIFT Nifty up; global cues strong from Wall Street and Asia. Key stocks to watch include ...

Dr. Reddy's Laboratories Limited RDY reported second-quarter fiscal 2026 earnings of 19 cents per American Depositary Share (ADS), which beat the Zacks Consensus Estimate of 18 cents. The company ...

HYDERABAD, India (AP) — HYDERABAD, India (AP) — Dr. Reddy's Laboratories Ltd. (RDY) on Friday reported earnings of $162 million in its fiscal second quarter. On a per-share basis, the Hyderabad, India ...